OpenLegislation

Regulation 16A Directions: compliance with first, second, third and fourth Directives as they apply in relation to Northern IrelandF1

United Kingdom

(1)

In relation to Northern Ireland, the Authority shall give directions to licence holders or designated individuals under section 23(1) of the 2004 Act, as applied by regulation 8, in accordance with Schedule 2 for the purpose of securing compliance with the requirements of the first, second, third and fourth Directives.

(2)

In relation to Northern Ireland, the Authority shall give such other directions to licence holders or designated individuals under section 23(1) of that Act, as applied by regulation 8, as it considers necessary for securing compliance by licence holders and third parties with any requirements of the first, second, third and fourth Directives.

Annotations

Textual amendments

F1

Reg. 16A inserted (31.12.2020) by The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(10A) (as inserted by S.I. 2020/1306, regs. 1, 14); 2020 c. 1, Sch. 5 para. 1(1)